HYBRID EVENT: You can participate in person at Barcelona, Spain from your home or work.

10th Edition of World Congress on Infectious Diseases

June 25-27, 2026 | Barcelona, Spain

June 25 -27, 2026 | Barcelona, Spain

Antiviral Therapies

Antiviral Therapies

Antiviral therapies play a crucial role in managing viral infections by targeting specific viruses to inhibit their replication and spread within the body. These therapies can vary widely depending on the virus being targeted and may include medications such as nucleoside analogs, protease inhibitors, and neuraminidase inhibitors. Nucleoside analogs, for example, work by interfering with viral DNA or RNA synthesis, thereby preventing the virus from replicating. Protease inhibitors, on the other hand, block the activity of viral proteases, essential enzymes required for viral replication. Neuraminidase inhibitors are commonly used to treat influenza viruses by inhibiting the activity of neuraminidase, an enzyme necessary for viral release from infected cells. While antiviral therapies can effectively reduce the severity and duration of viral infections, they may also be associated with side effects and the development of drug-resistant strains, highlighting the importance of ongoing research and development in this field.

Committee Members
Speaker at Infectious Diseases Conferences - Claudia Ferreira

Claudia Ferreira

Biophytis Sorbonne, France
Speaker at Infection Conferences - Yazdan Mirzanejad

Yazdan Mirzanejad

University of British Columbia, Canada
Speaker at Infectious Diseases Conferences - Saurabh Chattopadhyay

Saurabh Chattopadhyay

University of Kentucky College of Medicine, United States

Submit your abstract Today

Watsapp